ArticleCancer biology & therapy2011

Anticancer activity of Celastrol in combination with ErbB2-targeted therapeutics for treatment of ErbB2-overexpressing breast cancers.

Srikumar M Raja et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.